CHEMOURS CO/THE (CC) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CC - US1638511089 - Common Stock
11.87 USD
+0.26 (+2.24%)
11.87 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 76% to CC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.09. This target is 35.58% above the current price.
CC was analyzed by 18 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about CC.
In the previous month the buy percentage consensus was at a similar level.
CC was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-11 | UBS | Maintains | Buy -> Buy |
| 2025-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-09-23 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-28 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | UBS | Maintains | Buy -> Buy |
| 2025-04-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-01 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-27 | Mizuho | Upgrade | Neutral -> Outperform |
| 2025-02-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-01-28 | Truist Securities | Initiate | Buy |
| 2025-01-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-01-07 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-12-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-07 | BMO Capital | Maintains | Outperform -> Outperform |
CHEMOURS CO/THE / CC FAQ
Can you provide the average price target for CHEMOURS CO/THE stock?
18 analysts have analysed CC and the average price target is 16.09 USD. This implies a price increase of 35.58% is expected in the next year compared to the current price of 11.87.
How do analysts rate CHEMOURS CO/THE (CC)?
The consensus rating for CHEMOURS CO/THE (CC) is 75.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.